Abstract: A system for detecting moving objects within a predetermined geographical area is provided. The system is designed to convey object movement information from an airborne surveillance platform to a ground-based operator station with reduced data transmission. This is accomplished by computer processing image data on the surveillance platform prior to transmitting data to the ground station. First, the system constructs a 3D model of the area under surveillance, for example, by obtaining many different views of the area using an aircraft. One 3D model is maintained at the surveillance platform, and another is transmitted to the ground station. During a surveillance mission, a succession of relatively low data, 2D images are created and aligned with the surveillance platform's 3D model. The alignment reveals differences in the images (tracking data) which is then transmitted to the ground station for use with the ground station's 3D model to resolve object movement information.

Abstract: The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).

Abstract: A process of preparing a particulate and substantially crystalline drug substance. The process involves suspending a substantially crystalline drug substance in an anti-solvent to give a suspension, homogenising the suspension at elevated pressure to give drug particles that have a mean particle size of less than about 10 ?m, and drying the drug particles to remove any residual anti-solvent.

Abstract: The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).

Abstract: An insulated canister for, pressurized or non-pressurized systems, use with a metered dose system for example, a metered dose inhaler or topical aerosol featuring an inner container surrounded by an outer container with a gap defined by the space between the walls of the inner and outer container. Such gap can be filled by a vacuum, air or material with low thermal conductivity.